Ticker Scorecard - AXSM Basics Company: Axsome Therapeutics, Inc. IPO Date: November 19, 2015 Sector: Healthcare Industry: Biotech Market Cap: $4.22B Activated in VL: True Average Daily Range Avg Daily Range: $1.10 | 3.05% Avg Daily Range (30 D): $2.25 | 2.51% Avg Daily Range (90 D): $1.76 | 1.94% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): .71M Avg Daily Volume (90 D): .5M Trade Size Avg Trade Size (Sh.): 81 Avg Trade Size (Sh.) (30 D): 49 Avg Trade Size (Sh.) (90 D): 45 Institutional Trades Total Inst.Trades: 2,965 Avg Inst. Trade: $2.6M Avg Inst. Trade (30 D): $5.16M Avg Inst. Trade (90 D): $4.38M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.19M Avg Closing Trade (30 D): $8.67M Avg Closing Trade (90 D): $6.39M Avg Closing Volume: 51.38K     News Dec 30, 2024 @ 12:00 PM Axsome Therapeutics Announces Successful Completio... Source: N/A Nov 17, 2024 @ 12:05 PM Is It Too Late to Buy Viking Therapeutics Stock? Source: Prosper Junior Bakiny Oct 19, 2024 @ 11:30 AM 3 Bargain Stocks to Buy in a Market That's Priced ... Source: The Motley Fool Sep 29, 2024 @ 11:32 AM 1 Under-the-Radar Biotech Stock to Buy and Hold Source: Prosper Junior Bakiny Sep 6, 2024 @ 6:55 PM FDA Accepts AXSM's NDA Resubmission for Migraine D... Source: Zacks Financials   TTM Q3 2024 Q2 2024 Basic EPS $-6.58 $-1.34 $-1.67 Diluted EPS $-6.58 $-1.34 $-1.67 Revenue $ 338.46M $ 104.76M $ 87.17M Gross Profit $ $ $ Net Income / Loss $ -310.96M $ -64.6M $ -79.35M Operating Income / Loss $ -306.22M $ -62.62M $ -78.05M Cost of Revenue $ $ $ Net Cash Flow $ -89.22M $ 11.68M $ -15.78M PE Ratio